2026-03-23 Cerebrospinal fluid and plasma metabolites in Parkinson’s disease: a Mendelian randomization study
2026-03-20 Profiling of 5-hydroxymethylcytosine in blood reveals preferential enrichment at exon-intron junctions and predictive value for Parkinson’s disease
2026-03-17 Tribolium castaneum with longer duration of tonic immobility have more variations corresponding to the human Parkinson’s disease genomic region
2026-03-13 Gut microbiota modulation via repeated donor fecal transplantation improves motor and gastrointestinal symptoms in drug-naïve Parkinson’s disease: a randomized phase 2 trial
2026-03-03 Association between instrumental activities of daily living and incidence of Parkinson’s disease: a nationwide population-based cohort study
2026-02-20 The 201 Trial: a placebo-controlled randomized phase 2 study of safety and tolerance of the c-Abl kinase inhibitor risvodetinib in untreated Parkinson’s disease
2026-02-18 Early motor deficits, sleep dysfunction and reduction in dopaminergic neurons in a PARK7-/- zebrafish larval model of Parkinson’s disease
2026-02-16 MiniPromoters Ple384 (TH) and Ple388 (PITX3) for targeting midbrain dopaminergic neurons in mice and monkeys
2026-02-16 Nardosinone improves levodopa-induced dyskinesia in Parkinsonian rats through the microbiota–gut–brain axis
2026-02-13 Neuromelanin imaging outperforms free water imaging in diagnosing early Parkinson’s disease: a comparative MRI study
2026-02-12 WearGait-PD: An Open-Access Wearables Dataset for Gait in Parkinson’s Disease and Age-Matched Controls
2026-02-11 Single-cell analysis of the peripheral immune landscape in Parkinson’s disease: insights into dendritic cell and CD4+ T-cell transcriptomics
2026-02-11 Free water in the external globus pallidus predicts mild cognitive impairment in Parkinson’s disease and is associated with serum neurofilament light chain levels
2026-02-11 Wnt-3a exacerbates production of TNF-α in LPS stimulated microglia independent of the β-catenin canonical pathway
2026-02-10 Mitochondrial DNA drives NLRP3-IL-1β axis activation in microglia by binding to NLRP3, leading to neurodegeneration in Parkinson’s disease models
2026-02-10 Olfactory sensory map is perturbed in a human wild-type α-synuclein overexpressing transgenic mouse model of Parkinson’s disease
2026-02-09 Simulated depression risk classification from Parkinson’s voice features using a self-attention-enhanced MLP architecture
2026-02-07 Deep neurobehavioral phenotyping uncovers neural fingerprints of locomotor deficits in Parkinson’s disease
2026-02-07 LRRK2R1627P mutation amplifies environmental risk factors induced chronic inflammation and α-synuclein aggregation in the gut of rats
2026-02-07 Accessible assessment of motor and cognitive symptoms in Parkinson’s disease: integrating large datasets, machine-learning, and videoconferencing
2026-02-05 Chromatin accessibility and transcriptome in human neuronal model exposed to Parkinson’s environmental toxins
2026-02-04 A split biotin ligase approach reveals proteins associated with oligomeric alpha-synuclein during aggregation
2026-02-04 An ensemble machine learning classifier for Parkinson’s disease diagnosis using optical coherence tomography angiography
2026-02-03 Evaluation of c-Abl inhibitor vodobatinib in subjects with early Parkinson’s disease: a phase 2, randomized, double-blind, placebo-controlled study
2026-02-02 Association of LRRK2 p.A419V with Parkinson’s Disease in East Asians and analysis of age at onset
2026-02-02 Accelerated and localized synucleinopathy in a hybrid mouse model: implications for positron emission tomography studies
2026-01-31 Decoding the impact of visual states on adaptive deep brain stimulation feedback signals in movement disorders
2026-01-30 Metagenomics indicates an interplay of the microbiome and functional pathways in Parkinson’s disease
2026-01-29 Spinal cord stimulation therapy for gait impairment in Parkinson’s disease: a double-blinded, randomised feasibility trial with an open extension
2026-01-29 The graded effect of propofol in electrophysiology-guided navigation during deep brain stimulation surgery
2026-01-27 Systematic evaluation of mitochondrial morphology regulators for amelioration of neuronal α-synucleinopathy
2026-01-27 Evaluation of idiopathic olfactory dysfunction as a warning marker for early parkinson’s disease: a population-based cross-sectional study
2026-01-26 A multi-level annotated sensor dataset of gait freezing manifestations and severity in Parkinson’s disease
2026-01-23 Evaluation of the neurotrophic peptide mixture in pathogenetic therapy of patients with Parkinson’s disease
2026-01-23 Clinical utility of evoked potentials for programming subthalamic deep brain stimulation in Parkinsons disease
2026-01-22 Comparative effects of medication combined with twenty rehabilitation therapies: core outcomes in 8202 parkinson’s patients
2026-01-22 Iterative multiblock framework for high frequency EEG based neurological disorder detection
2026-01-21 Inhibition of de novo ceramide synthesis mitigates alpha-synuclein pathology in a Parkinson’s disease mouse model
2026-01-21 Association of a five-metabolite and early-symptom profile with Parkinson’s disease and its clinical progression
2026-01-20 C1q-dependent clearance of alpha-synuclein allows macrophages to transiently limit enteric synucleinopathy in male mice
2026-01-20 Emotion recognition from faces and bodies in Parkinson’s disease and its relationship to MRI-based brain volumetry
2026-01-20 The effect of dopamine D2-like receptor blockade on human motor performance and skill acquisition
2026-01-19 Glycerol 3-phosphate acyltransferase exacerbates α-synuclein-induced toxicity by increasing lipid peroxidation
2026-01-18 Elevated cerebral oxygen extraction fraction in Parkinson’s disease correlates with motor impairment severity
2026-01-17 The association between probable sarcopenia, non-motor symptoms, and fall-related outcomes in parkinson’s disease
2026-01-15 Early retinal synaptic dysfunction and proteomic remodeling precede neurodegeneration in a Parkinson’s disease model
2026-01-13 Impact of dual-tasking and balance confidence on turns and transitions: a cross-sectional study in Parkinson’s disease
2026-01-10 Disruption of intracellular iron homeostasis through mitochondrial dysfunction associated with suppression of ATP 13A2 expression
2026-01-08 Dynamic thalamocortical functional connectivity disruptions in Parkinson’s disease with probable REM sleep behavior disorder